[Visceral leishmaniasis refractory to treatment: the efficacy of amphotericin B].
Pérez Brea
A
A
Servicio de Pediatría de la F.J.D., Clínica de Ntra. Sra. de la Concepción, Madrid.
Ruiz Moreno
M
M
Leal Orozco
A
A
Escorihuela Esteban
R
R
Otero Fraguas
M
M
D000666:Amphotericin B / Q000627:therapeutic use*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000965:Antimony / Q000037:antagonists & inhibitors; D000981:Antiprotozoal Agents / Q000037:antagonists & inhibitors; D002675:Child, Preschool; D002908:Chronic Disease; D004351:Drug Resistance; D006801:Humans; D007893:Leishmania donovani; D007898:Leishmaniasis, Visceral / Q000175:diagnosis / Q000188:drug therapy* / Q000208:ethnology; D008297:Male; D006178:Romani People; D013030:Spain / Q000453:epidemiology
D000900:Anti-Bacterial Agents; D000981:Antiprotozoal Agents; D000666:Amphotericin B; D000965:Antimony